Global pharma giant Sanofi and Chinese company Innovent Biologics have penned a strategic partnership to develop and commercialize innovative treatments for patients with hard-to-treat cancers in China.
https://www.pharmalive.com/wp-content/uploads/2021/04/Sanofi-Partners-With-Moderna-to-Answer-Global-Demand-for-COVID-19-Vaccines-BioSpace-4-26-21.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-05 11:07:052022-08-05 11:07:05Sanofi expands China footprint with Innovent collaboration
